Use of magnesium sulfate to treat severe preeclampsia and eclampsia in Mexico
Presentation at Population Association of America Annual Meeting, Detroit, 2 May
Garcia,Sandra G.; van Dijk,Marieke G.; Sanhueza,Patricio; Wilson,Katherine
Publication date: 2009
In order to better understand why magnesium sulfate (MS) is not used routinely for women with severe preeclampsia or eclampsia in Mexican public health services, we are conducting three complementary quantitative and qualitative studies: self-administered questionnaires among physicians of Ministry of Health hospitals in Mexico City, in-depth interviews with 13 key informants, and a chart review of women who died of (pre)eclampsia in Mexico City in 2005, 2006, and 2007 (still in process). Physicians who responded to the questionnaire reported a high preference for MS: 79 percent stated that MS was their preferred drug in patients with preeclampsia, and 46 percent said it was for eclampsia. However, our key informants contradicted these findings. They identified several barriers for the use of MS among gynecologists. The results of the chart review will provide invaluable information about the actual use of MS in Mexico, which we will compare with the findings of the other studies.